Login to Your Account


Firm admits no wrongdoing
Rather than going to trial Monday, Teva Pharmaceutical Industries Ltd. agreed to pay at least $1.2 billion to settle a 2008 FTC lawsuit challenging pay-for-delay agreements Cephalon Inc. used to fend off generic competition to its blockbuster sleep-disorder drug Provigil. more »